Receptor PET/CT Imaging of Neuroendocrine Tumours Using the Ga-68 Labelled, High Affinity Somatostatin Analogue DOTA-1-Nal3-octreotide (DOTA-NOC): Clinical Results in 327 Patients

被引：0
|
作者：
Baum, R. P. [1 ]
Niesen, A. [1 ]
Leonhardi, J. [1 ]
Wortmann, R. [1 ]
Mueller, D. [1 ]
Roesch, F. [2 ]
机构：
[1] Zent Klin Bad Berka, Bad Berka, Germany
[2] Johannes Gutenberg Univ Mainz, Inst Nucl Chem, D-55122 Mainz, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2005年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S54 / S55
页数：2
相关论文
共 28 条
  • [1] Highly Variable Biodistribution of 68Ga Labeled Somatostatin Analogue DOTA-NOC/TATE in Neuroendocrine Tumors: Clinical Implications for Somatostatin Receptor Directed PET/CT
    Cheng, Monica
    Tann, Mark
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [2] Incidence and detection of cardiac metastases in patients wih neuroendocrine tumors (NET): Role of Ga-68 DOTA-NOC receptor PET/CT
    Prasad, V.
    Secknus, M. A.
    Lauer, B.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S193 - S193
  • [3] Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions
    Prasad, V.
    Baum, R. P.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 54 (01): : 61 - 67
  • [4] Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours: preliminary results
    Demirci, Emre
    Ocak, Meltem
    Kabasakal, Levent
    Araman, Ahmet
    Ozsoy, Yildiz
    Kanmaz, Bedii
    NUCLEAR MEDICINE COMMUNICATIONS, 2013, 34 (08) : 727 - 732
  • [5] Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide
    Daniel Putzer
    Alexander Kroiss
    Dietmar Waitz
    Michael Gabriel
    Tatjana Traub-Weidinger
    Christian Uprimny
    Elisabeth von Guggenberg
    Clemens Decristoforo
    Boris Warwitz
    Gerlig Widmann
    Irene Johanna Virgolini
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 364 - 372
  • [6] Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide
    Putzer, Daniel
    Kroiss, Alexander
    Waitz, Dietmar
    Gabriel, Michael
    Traub-Weidinger, Tatjana
    Uprimny, Christian
    von Guggenberg, Elisabeth
    Decristoforo, Clemens
    Warwitz, Boris
    Widmann, Gerlig
    Virgolini, Irene Johanna
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (03) : 364 - 372
  • [7] Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma
    Sharma, Punit
    Arora, Saurabh
    Karunanithi, Sellam
    Khadgawat, Rajesh
    Durgapal, Prashant
    Sharma, Raju
    Kandasamy, Devasenathipathy
    Bal, Chandrasekhar
    Kumar, Rakesh
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 60 (01): : 69 - 76
  • [8] 68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
    Gabriel, Michael
    Decristoforo, Clemens
    Kendler, Dorota
    Dobrozemsky, Georg
    Heute, Dirk
    Uprimny, Christian
    Kovacs, Peter
    Von Guggenberg, Elisabeth
    Bale, Reto
    Virgolini, Irene J.
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 : 189S - 198S
  • [9] 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT
    Gabriel, Michael
    Decristoforo, Clemens
    Kendler, Dorota
    Dobrozemsky, Georg
    Heute, Dirk
    Uprimny, Christian
    Kovacs, Peter
    Von Guggenberg, Elisabeth
    Bale, Reto
    Virgolini, Irene J.
    JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (04) : 508 - 518
  • [10] Detection of unknown primary neuroendocrine tumors (CUP-NET) using 68Ga DOTA-NOC receptor PET/CT
    Hoersch, D.
    Prasad, V.
    Ambrosini, V.
    Hommann, M.
    Fanti, S.
    Baum, R. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
123